Clinical Trials Logo

Constriction clinical trials

View clinical trials related to Constriction.

Filter by:
  • None
  • Page 1

NCT ID: NCT05248087 Completed - Constriction Clinical Trials

Pain, Discomfort, and Functional Impairments During Maxillary Expansion

Start date: February 20, 2020
Phase: N/A
Study type: Interventional

Maxillary expansion is associated with varying degrees of pain and functional impairments. The current study aims to compare rapid maxillary expansion using a McNamara-type (bonded) appliance and slow maxillary expansion using a removable palatal expansion appliance concerning patient-centered outcomes. Those outcomes will include pain and discomfort, mastication difficulties, swallowing difficulties, and pressure on the soft tissues.

NCT ID: NCT02937389 Completed - Clinical trials for Esophageal Neoplasms

Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy

Start date: May 2015
Phase:
Study type: Observational

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

NCT ID: NCT02703142 Completed - Clinical trials for Esophageal Neoplasms

Endoscopic Evaluation After Esophagectomy

Start date: October 2015
Phase: N/A
Study type: Observational

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

NCT ID: NCT02177266 Not yet recruiting - Atrial Fibrillation Clinical Trials

Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation

Start date: June 2014
Phase: Phase 3
Study type: Interventional

The study will determine the benefit of Colchicine versus placebo for cardiac surgery patients on the post-operative development of atrial fibrillation and post-pericardiotomy syndrome. Primary Objective. Colchicine will reduce the composite endpoint of incidence of post-operative atrial fibrillation and post-pericardiotomy syndrome at 3 months following cardiac surgery. Secondary Objectives. 1. Colchicine will reduce the incidence of constrictive physiology on echocardiography at 3 months following cardiac surgery. 2. Reduction in the burden of symptomatic and asymptomatic atrial fibrillation in the 3 months following cardiac surgery with the use of colchicine.